Clinical trials rebound after COVID-19 setbacks, and early treatment leads to significant reduction in anal cancer risk among people with HIV.

by Thomas Celona

A new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.

by Eric Fitzsimmons

A blood test could help determine who benefits from checkpoint inhibitors in lung cancer, and the FDA approves a drug combination for certain patients with acute myeloid leukemia.

by Marci A. Landsmann

Esophageal cancer increases in the middle-aged, and adolescent and young adult leukemia survivors face continued mortality risk after treatment ends.

by Eric Fitzsimmons

From the Editor-in-Chief

Is it the beginning of the end or the end of the beginning?

by William G. Nelson, MD, PhD

First child to receive CAR T-cell therapy celebrates 10 years cancer-free, and authorization denials delay treatment for patients with Medicare Advantage.

by Marci A. Landsmann

Adolescents and young adult cancer survivors at higher risk for dying from a new cancer diagnosis, and FDA grants full approval to Enhertu for metastatic HER2-postive breast cancer.

by Eric Fitzsimmons

As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.

by Jon Kelvey

FDA proposes ban on menthol cigarettes, and proton beam therapy on the rise but with growing racial disparity.

by Thomas Celona

Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical trials.

by Kevin McLaughlin